[Federal Register Volume 79, Number 199 (Wednesday, October 15, 2014)]
[Notices]
[Page 61908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-24512]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Application for a License To Export High-Enriched Uranium

    Pursuant to 10 CFR 110.70(b) ``Public Notice of Receipt of an 
Application,'' please take notice that the Nuclear Regulatory 
Commission (NRC) has received the following request for an export 
license. Copies of the request are available electronically through 
ADAMS and can be accessed through the Public Electronic Reading Room 
(PERR) link http://www.nrc.gov/reading-rm.html at the NRC Homepage.
    A request for a hearing or petition for leave to intervene may be 
filed within thirty days after publication of this notice in the 
Federal Register. Any request for hearing or petition for leave to 
intervene shall be served by the requestor or petitioner upon the 
applicant, the office of the General Counsel, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555; the Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555; and the Executive 
Secretary, U.S. Department of State, Washington, DC 20520.
    A request for a hearing or petition for leave to intervene may be 
filed with the NRC electronically in accordance with NRC's E-Filing 
rule promulgated in August 2007, 72 FR 49139; August 28, 2007. 
Information about filing electronically is available on the NRC's 
public Web site at http://www.nrc.gov/site-help/e-submittals.html. To 
ensure timely electronic filing, at least five days prior to the filing 
deadline, the petitioner/requestor should contact the Office of the 
Secretary by email at [email protected], or by calling (301) 415-
1677, to request a digital ID certificate and allow for the creation of 
an electronic docket.
    In addition to a request for hearing or petition for leave to 
intervene, written comments, in accordance with 10 CFR 110.81, should 
be submitted within thirty days after publication of this notice in the 
Federal Register to Office of the Secretary, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555, Attention: Rulemaking and 
Adjudications.
    The information concerning this application for an export license 
follows.

                                         NRC Export License Application
                                            [Description of material]
----------------------------------------------------------------------------------------------------------------
   Name of applicant, date of
   application, date received,       Material type        Total quantity          End use          Destination
   application No., docket No.
----------------------------------------------------------------------------------------------------------------
DOE/NNSA--Y-12 National Security  High-Enriched        7.28 kilograms       To fabricate        Belgium.
 Complex, September 18, 2014,      Uranium (93.35%).    uranium-235          targets at CERCA
 September 22, 2014, XSNM3756,                          contained in 7.8     AREVA Romans in
 11006175.                                              kilograms uranium.   France and to
                                                                             irradiate targets
                                                                             at the BR-2
                                                                             Research Reactor
                                                                             in Belgium, the
                                                                             HFR Research
                                                                             Reactor in the
                                                                             Netherlands, the
                                                                             OSIRIS Research
                                                                             Reactor in
                                                                             France, the LVR-
                                                                             15 Research
                                                                             Reactor in Czech
                                                                             Republic, and the
                                                                             Maria Reactor in
                                                                             Poland, for
                                                                             ultimate use for
                                                                             production of
                                                                             medical isotopes
                                                                             at the Institute
                                                                             for Radioelements
                                                                             in Belgium.
----------------------------------------------------------------------------------------------------------------


    For the Nuclear Regulatory Commission.

    Dated this 8th day of October 2014 at Rockville, Maryland.
David L. Skeen,
Deputy Director, Office of International Programs.
[FR Doc. 2014-24512 Filed 10-14-14; 8:45 am]
BILLING CODE 7590-01-P